Endosome (late 3)

[{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a0eb23b59f1200cf2308/5bf45ac760a7c41200c5ee98.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a0eb23b59f1200cf2308/5bf45ac760a7c41200c5ee98.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a0eb23b59f1200cf2307/5bf45ac760a7c41200c5ee98.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a0eb23b59f1200cf2307/5bf45ac760a7c41200c5ee98.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a0eb23b59f1200cf2306/5bf45ac760a7c41200c5ee98.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a0eb23b59f1200cf2306/5bf45ac760a7c41200c5ee98.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a0eb23b59f1200cf2305/5bf45ac760a7c41200c5ee98.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a0eb23b59f1200cf2305/5bf45ac760a7c41200c5ee98.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a0eb23b59f1200cf2304/5bf45ac760a7c41200c5ee98.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a0eb23b59f1200cf2304/5bf45ac760a7c41200c5ee98.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a0eb23b59f1200cf2303/5bf45ac760a7c41200c5ee98.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a0eb23b59f1200cf2303/5bf45ac760a7c41200c5ee98.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a0eb23b59f1200cf2302/5bf45ac760a7c41200c5ee98.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a0eb23b59f1200cf2302/5bf45ac760a7c41200c5ee98.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a0eb23b59f1200cf2301/5bf45ac760a7c41200c5ee98.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a0eb23b59f1200cf2301/5bf45ac760a7c41200c5ee98.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a0eb23b59f1200cf2300/5bf45ac760a7c41200c5ee98.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a0eb23b59f1200cf2300/5bf45ac760a7c41200c5ee98.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a0eb23b59f1200cf22ff/5bf45ac760a7c41200c5ee98.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a0eb23b59f1200cf22ff/5bf45ac760a7c41200c5ee98.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a0eb23b59f1200cf22fe/5bf45ac760a7c41200c5ee98.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a0eb23b59f1200cf22fe/5bf45ac760a7c41200c5ee98.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a0eb23b59f1200cf22fd/5bf45ac760a7c41200c5ee98.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a0eb23b59f1200cf22fd/5bf45ac760a7c41200c5ee98.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a0eb23b59f1200cf22fc/5bf45ac760a7c41200c5ee98.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a0eb23b59f1200cf22fc/5bf45ac760a7c41200c5ee98.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a0eb23b59f1200cf22fb/5bf45ac760a7c41200c5ee98.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a0eb23b59f1200cf22fb/5bf45ac760a7c41200c5ee98.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/5bf5a0eb23b59f1200cf22fa/5bf45ac760a7c41200c5ee98.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/5bf5a0eb23b59f1200cf22fa/5bf45ac760a7c41200c5ee98.png"}]